Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Older periods | Mar '24 | Jun '24 | Sep '24 | Dec '24 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(54.21%) | (61.33%) | (46.52%) | (31.54%) | |
| (30.68%) | (34.41%) | (25.02%) | (18.03%) | ||
ROIC |
(36.35%) | (49.95%) | (44.64%) | (31.42%) | |
Return on Tangible Assets |
(93.62%) | (95.64%) | (66.70%) | (44.02%) | |
Average Days of Receivables |
65.85 | 53.98 | 60.18 | 46.80 | |
Free Cash Flow per Share |
(0.30) | (0.15) | 0.07 | 0.13 | |
Free Cash Flow |
(1.77) | (0.85) | 0.42 | 0.79 | |
Capital Expenditures |
(0.04) | (0.20) | (0.15) | (0.14) | |
Piotroski F-Score |
4.00 | 5.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
(21.79%) | (9.05%) | 8.28% | 14.08% | |
Accounts Receivable Turnover |
5.42 | 5.87 | 4.87 | 6.32 | |
Accounts Payable Turnover |
13.85 | 17.66 | 13.79 | 20.73 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
31.12 | 18.64 | 29.06 | 13.40 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.28 | 0.32 | 0.01 | (0.03) | |
Research and Development Expense of Revenue |
4.89% | 4.61% | 4.22% | 3.80% | |
Selling, General and Administrative Expense of Revenue |
47.39% | 49.58% | 48.60% | 41.88% | |
Share Based Compensation of Revenue |
4.76% | 5.64% | 4.99% | 4.66% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.39 | 0.14 | (0.19) | (0.50) | |
Depreciation/Fixed assets |
0.91 | 0.99 | 1.00 | 1.04 | |
Capex/Depreciation |
(0.02) | (0.08) | (0.07) | (0.07) | |
Revenue per Share |
3.72 | 3.57 | 3.44 | 3.36 | |
Operating CF per Share |
(0.30) | (0.11) | 0.10 | 0.16 | |
Capex per Share |
(0.01) | (0.03) | (0.03) | (0.02) | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(20.64%) | (21.93%) | (14.78%) | (9.45%) |
Columns are period end dates